These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 21118546)

  • 1. Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development.
    Staneková Z; Varečková E
    Virol J; 2010 Nov; 7():351. PubMed ID: 21118546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterosubtypic protective immunity against influenza A virus induced by fusion peptide of the hemagglutinin in comparison to ectodomain of M2 protein.
    Staneková Z; Király J; Stropkovská A; Mikušková T; Mucha V; Kostolanský F; Varečková E
    Acta Virol; 2011; 55(1):61-7. PubMed ID: 21434706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of virus-specific cytotoxic T lymphocytes as a basis for the development of broadly protective influenza vaccines.
    Hillaire ML; Osterhaus AD; Rimmelzwaan GF
    J Biomed Biotechnol; 2011; 2011():939860. PubMed ID: 22007149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different mechanisms of the protection against influenza A infection mediated by broadly reactive HA2-specific antibodies.
    Tomčíková K; Varečková E
    Acta Virol; 2019; 63(4):347-365. PubMed ID: 31802678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses.
    Goff PH; Hayashi T; Martínez-Gil L; Corr M; Crain B; Yao S; Cottam HB; Chan M; Ramos I; Eggink D; Heshmati M; Krammer F; Messer K; Pu M; Fernandez-Sesma A; Palese P; Carson DA
    J Virol; 2015 Mar; 89(6):3221-35. PubMed ID: 25568203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.
    Sambhara S; Kurichh A; Miranda R; Tumpey T; Rowe T; Renshaw M; Arpino R; Tamane A; Kandil A; James O; Underdown B; Klein M; Katz J; Burt D
    Cell Immunol; 2001 Aug; 211(2):143-53. PubMed ID: 11591118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
    Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pandemic preparedness: toward a universal influenza vaccine.
    Roose K; Fiers W; Saelens X
    Drug News Perspect; 2009 Mar; 22(2):80-92. PubMed ID: 19330167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine.
    Tsybalova LM; Stepanova LA; Shuklina MA; Mardanova ES; Kotlyarov RY; Potapchuk MV; Petrov SA; Blokhina EA; Ravin NV
    PLoS One; 2018; 13(8):e0201429. PubMed ID: 30138320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Return of inactivated whole-virus vaccine for superior efficacy.
    Furuya Y
    Immunol Cell Biol; 2012 Jul; 90(6):571-8. PubMed ID: 21844883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Universal influenza vaccines, science fiction or soon reality?
    de Vries RD; Altenburg AF; Rimmelzwaan GF
    Expert Rev Vaccines; 2015; 14(10):1299-301. PubMed ID: 26104835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses to influenza virus infection.
    Kreijtz JH; Fouchier RA; Rimmelzwaan GF
    Virus Res; 2011 Dec; 162(1-2):19-30. PubMed ID: 21963677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards a universal influenza vaccine: different approaches for one goal.
    Sautto GA; Kirchenbaum GA; Ross TM
    Virol J; 2018 Jan; 15(1):17. PubMed ID: 29370862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell response.
    Testa JS; Shetty V; Hafner J; Nickens Z; Kamal S; Sinnathamby G; Philip R
    PLoS One; 2012; 7(11):e48484. PubMed ID: 23144892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant impact of sequence variations in the nucleoprotein on CD8 T cell-mediated cross-protection against influenza A virus infections.
    Zhong W; Liu F; Dong L; Lu X; Hancock K; Reinherz EL; Katz JM; Sambhara S
    PLoS One; 2010 May; 5(5):e10583. PubMed ID: 20485501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Universal influenza vaccines: developments, prospects for use].
    Tsybalova LM; Kiselev OI
    Vopr Virusol; 2012; 57(1):9-14. PubMed ID: 22624467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus-specific T cells as correlate of (cross-)protective immunity against influenza.
    Altenburg AF; Rimmelzwaan GF; de Vries RD
    Vaccine; 2015 Jan; 33(4):500-6. PubMed ID: 25498210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine approaches conferring cross-protection against influenza viruses.
    Vemula SV; Sayedahmed EE; Sambhara S; Mittal SK
    Expert Rev Vaccines; 2017 Nov; 16(11):1141-1154. PubMed ID: 28925296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperativity between CD8+ T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity.
    Laidlaw BJ; Decman V; Ali MA; Abt MC; Wolf AI; Monticelli LA; Mozdzanowska K; Angelosanto JM; Artis D; Erikson J; Wherry EJ
    PLoS Pathog; 2013 Mar; 9(3):e1003207. PubMed ID: 23516357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Improved Inactivated Influenza Vaccine with Enhanced Cross Protection.
    Ni Y; Guo J; Turner D; Tizard I
    Front Immunol; 2018; 9():1815. PubMed ID: 30140267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.